These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16876654

  • 21. The development of albendazole for lymphatic filariasis.
    Horton J.
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [Abstract] [Full Text] [Related]

  • 22. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
    Selve BP, Bwadua S, Misa M, James K, Usurup JP, Turner P, Melrose W, Yad W, Samuel R, Eddie C.
    P N G Med J; 2000 Oct; 43(3-4):183-7. PubMed ID: 11939299
    [Abstract] [Full Text] [Related]

  • 23. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV, Kar SK.
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [Abstract] [Full Text] [Related]

  • 24. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct 01; 79(40):358-65. PubMed ID: 15631012
    [No Abstract] [Full Text] [Related]

  • 25. Modelling the epidemiology, transmission and control of lymphatic filariasis.
    Das PK, Subramanian S.
    Ann Trop Med Parasitol; 2002 Dec 01; 96 Suppl 2():S153-64. PubMed ID: 12625928
    [Abstract] [Full Text] [Related]

  • 26. Migration and dispersal of lymphatic filariasis in Papua New Guinea.
    Alexander ND, Bockarie MJ, Dimber ZB, Griffin L, Kazura JW, Alpers MP.
    Trans R Soc Trop Med Hyg; 2001 Dec 01; 95(3):277-9. PubMed ID: 11490996
    [No Abstract] [Full Text] [Related]

  • 27. Lymphatic filariasis: constraints ahead.
    Mishra CP, Singh N.
    Indian J Public Health; 2003 Dec 01; 47(1):27-30. PubMed ID: 14723292
    [No Abstract] [Full Text] [Related]

  • 28. Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
    Abd Elaziz KM, El-Setouhy M, Bradley MH, Ramzy RM, Weil GJ.
    Am J Trop Med Hyg; 2013 Aug 01; 89(2):260-4. PubMed ID: 23751402
    [Abstract] [Full Text] [Related]

  • 29. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov 30; 87(48):478-82. PubMed ID: 23213667
    [No Abstract] [Full Text] [Related]

  • 30. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU, King CL, Jacobson JA, Weil GJ.
    PLoS Negl Trop Dis; 2017 Jan 30; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract] [Full Text] [Related]

  • 31. A brief introduction to the research achievement on the strategy and technical measures for interrupting the transmission of lymphatic filariasis in China.
    Shi ZJ, Sun DJ, Wang ZJ, Tao ZH, Pan SX, Liu XJ, Zhang SQ, Ou ZY, Zhu SZ, Li QJ, Chang J, Wu RZ, Deng SS, Zheng XQ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001 Jan 30; 19(2):110-2. PubMed ID: 12572001
    [No Abstract] [Full Text] [Related]

  • 32. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M, Lepaitai HB, Bhagirov R, Padmasiri E, Naseri T, Thomsen R, Won KY, Brant TA, Dodd E, Nua MT, Utu F, Tufa A, Chutaro E, Camacho J, Suiaunoa-Scanlan L, Thean LJ, Mani J, Hardy M, Samuela J, Romani L, Kaldor J, Steer AC, Faktaufon D, Bechu V, Naqio F, Sosene V, Sekihara M, Otaki J, Buhagiar TS, Yajima A.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):39-47. PubMed ID: 35292579
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
    Irvine MA, Stolk WA, Smith ME, Subramanian S, Singh BK, Weil GJ, Michael E, Hollingsworth TD.
    Lancet Infect Dis; 2017 Apr 11; 17(4):451-458. PubMed ID: 28012943
    [Abstract] [Full Text] [Related]

  • 34. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995 Apr 11; 13(2):81-5. PubMed ID: 7554168
    [Abstract] [Full Text] [Related]

  • 35. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
    Tripathi B, Roy N, Dhingra N.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):29-38. PubMed ID: 35292580
    [Abstract] [Full Text] [Related]

  • 36. Elimination of lymphatic filariasis as a public health problem.
    Cox FE.
    Parasitol Today; 2000 Apr 11; 16(4):135. PubMed ID: 10725894
    [No Abstract] [Full Text] [Related]

  • 37. Major progress toward eliminating lymphatic filariasis.
    Ottesen EA.
    N Engl J Med; 2002 Dec 05; 347(23):1885-6. PubMed ID: 12466515
    [No Abstract] [Full Text] [Related]

  • 38. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R, Sunish IP, Mani TR, Munirathinam A, Arunachalam N, Satyanarayana K, Dash AP.
    Trop Med Int Health; 2006 Jun 05; 11(6):851-61. PubMed ID: 16772007
    [Abstract] [Full Text] [Related]

  • 39. Albendazole for the control and elimination of lymphatic filariasis: systematic review.
    Critchley J, Addiss D, Ejere H, Gamble C, Garner P, Gelband H, International Filariasis Review Group.
    Trop Med Int Health; 2005 Sep 05; 10(9):818-25. PubMed ID: 16135187
    [Abstract] [Full Text] [Related]

  • 40. Strategies and tools for the control/elimination of lymphatic filariasis.
    Ottesen EA, Duke BO, Karam M, Behbehani K.
    Bull World Health Organ; 1997 Sep 05; 75(6):491-503. PubMed ID: 9509621
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.